In summary, our data demonstrate that FABP3 is expressed in endothelial cells and that loss of endothelial FABP3 inhibits LPS-induced endothelial dysfunction by modulating cell survival and inflammatory and angiogenic signaling pathways. The gene discussed is FABP3; the disease is endothelial dysfunction.